We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.

We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.
Logo - Business Development Bank of Canada - BDC
Zymeworks logo
Portfolio company

Zymeworks

Details
Region
Prairies and West
Industry sector
Drugs
Investment year
2016
Fund
Healthcare Venture Fund
Learn more
Our partnership

Zymeworks is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Dion Madsen, Founding partner at Amplitude Venture Capital.

About the company

Zymeworks is a privately held biotherapeutics company that is developing best-in-class Azymetric™ bi-specific antibodies and antibody drug conjugates for the treatment of cancer, autoimmune and inflammatory diseases. The company’s novel Azymetric™, AlbuCORE™, and EFECT™ platforms, and its proprietary ZymeCAD™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies and multivalent protein therapeutics across a range of indications. Zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations.